https://dapagliflozininhibitor.....com/diversity-regar
Here we introduce an approach (provided as R-package) when it comes to quantification associated with the dose-response effectiveness of a gene-signature as EC50 and IC50 values. Two signaling pathways were utilized as designs to verify our methods beta-adrenergic agonistic activity on cAMP generation (committed dataset created for this research) and EGFR inhibitory impact on cancer cell viability. Both in situations, potencies based on multi-gene appearance informat
Like
Comment
Share
